Related Experiment Video
Updated: Oct 26, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Therapeutic Plasma Exchange with Continuous Renal Replacement Therapy for Pediatric Acute Liver Failure: A Case
Sirawut Trepatchayakorn1, Nataruks Chaijitraruch1, Voranush Chongsrisawat1
1Department of Pediatrics, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Insights
Therapeutic plasma exchange with high-volume continuous renal replacement therapy (TPE + HV-CRRT) shows promise for pediatric acute liver failure (PALF). This supportive treatment improved outcomes, aiding survival and liver recovery in children.
Area of Science:
- Pediatric critical care medicine
- Hepatology
- Extracorporeal therapies
Background:
- Pediatric acute liver failure (PALF) is a critical condition with limited evidence-based treatment options.
- Extracorporeal support is utilized for toxic metabolite clearance and as a bridge to liver transplantation (LT) or regeneration.
Observation:
- A case series reviewed eight PALF patients (9 months to 14 years) treated with TPE + HV-CRRT.
- Data collected included demographics, indications, technical aspects, and clinical outcomes from January 2016 to September 2019.
Findings:
- TPE + HV-CRRT improved serum bilirubin and coagulation studies in PALF patients.
- Complications included hemodynamic instability, fluid overload, and bleeding; 75% of patients survived, with 50% undergoing successful LT and 25% achieving spontaneous recovery.
Implications:
- TPE + HV-CRRT is a safe bridging therapy for pediatric acute liver failure.
- Higher TPE volumes or blood flow rates in pediatric patients may correlate with hemodynamic instability, requiring careful monitoring.
Aim And Objective:
Pediatric acute liver failure (PALF) is a life-threatening condition. Extracorporeal support has been applied for toxic metabolite clearance and serves as a bridging therapy to liver transplantation (LT) or to the regeneration of the liver, but evidence for treatment approaches is still lacking in the pediatric population. We aim to report our experience on therapeutic plasma exchange with high-volume continuous renal replacement therapy (TPE + HV-CRRT) as a promising supportive treatment for PALF.
Materials And Methods:
A total of eight PALF cases aged 9 months to 14 years, weighing 10-50 kg., who were admitted to PICU King Chulalongkorn Memorial Hospital, Thailand and treated with TPE + HV-CRRT from January 2016 to September 2019 were reviewed. Patient demographic data, indications, technical aspects, and clinical outcomes were recorded.
Results:
All patients who underwent TPE + HV-CRRT showed clinical improvement regarding serum bilirubin levels and coagulation studies after the therapy. Complications from the therapy were hemodynamic instability, symptomatic fluid overload, and bleeding from catheter sites. Among these, 6 (75%) patients survived with 4 (50%) successful LTs and 2 (25%) spontaneous recovery. Two children (25%) died while on the transplantation list.
Conclusion:
TPE + HV-CRRT can be used safely as a bridging therapy in children with PALF. As opposed to the adult population, higher volume of TPE or higher blood flow rate in pediatric patients might associate with hemodynamic instability during the procedure.
How To Cite This Article:
Trepatchayakorn S, Chaijitraruch N, Chongsrisawat V, Chanakul A, Kongkiattikul L, Samransamruajkit R. Therapeutic Plasma Exchange with Continuous Renal Replacement Therapy for Pediatric Acute Liver Failure: A Case Series from Thailand. Indian J Crit Care Med 2021;25(7):812-816.
More Related Videos
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Acute Kidney Injury V: Interprofessional Care
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Pharmacokinetics in Pediatric Patients: Drug Excretion

